Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce A Feinberg

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
JAMA Oncology|November 14, 2018
Orphan Cancer Drugs in the Era of Precision MedicineChadi Nabhan, Eli G Phillips, Bruce A Feinberg
American Journal of Hematology|October 22, 2016
Clinical pathways in chronic lymphocytic leukemia: Challenges and solutionsChadi Nabhan, Anthony R Mato, Bruce A Feinberg
JCO Precision Oncology|February 17, 2022
Real-World Evidence and Randomized Studies in the Precision Oncology Era: The Right BalanceBishal Gyawali, Sandeep Parsad, Bruce A Feinberg, et al.
The American Journal of Managed Care|March 17, 2017
CAR-T cells: the next era in immuno-oncologyBruce A Feinberg, Jennifer Fillman, Justin Simoncini, et al.
JAMA Oncology|July 21, 2017
Biosimilars in Oncology in the United States: A ReviewChadi Nabhan, Sandeep Parsad, Anthony R Mato, et al.
BMJ Open|October 7, 2021
Impact of social determinants of health on cancer care: a survey of community oncologistsMarjorie E Zettler, Bruce A Feinberg, Yolaine Jeune-Smith, et al.
Future Oncology (London, England)|June 1, 2018
Using Response Evaluation Criteria in Solid Tumors in real-world evidence cancer researchBruce A Feinberg, Murtuza Bharmal, Andrew J Klink, et al.
Advances in Therapy|January 25, 2021
Effectiveness of Eribulin in Metastatic Breast Cancer: 10 Years of Real-World Clinical Experience in the United StatesSarah S Mougalian, Jonathan K Kish, Jingchuan Zhang, et al.
Advances in Therapy|May 16, 2021
Correction to: Effectiveness of Eribulin in Metastatic Breast Cancer: 10 Years of Real-World Clinical Experience in the United StatesSarah S Mougalian, Jonathan K Kish, Jingchuan Zhang, et al.
Advances in Therapy|April 7, 2021
Correction to: Effectiveness of Eribulin in Metastatic Breast Cancer: 10 Years of Real-World Clinical Experience in the United StatesSarah S Mougalian, Jonathan K Kish, Jingchuan Zhang, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
JAMA Oncology|November 14, 2018
Orphan Cancer Drugs in the Era of Precision MedicineChadi Nabhan, Eli G Phillips, Bruce A Feinberg
American Journal of Hematology|October 22, 2016
Clinical pathways in chronic lymphocytic leukemia: Challenges and solutionsChadi Nabhan, Anthony R Mato, Bruce A Feinberg
JCO Precision Oncology|February 17, 2022
Real-World Evidence and Randomized Studies in the Precision Oncology Era: The Right BalanceBishal Gyawali, Sandeep Parsad, Bruce A Feinberg, et al.
The American Journal of Managed Care|March 17, 2017
CAR-T cells: the next era in immuno-oncologyBruce A Feinberg, Jennifer Fillman, Justin Simoncini, et al.
JAMA Oncology|July 21, 2017
Biosimilars in Oncology in the United States: A ReviewChadi Nabhan, Sandeep Parsad, Anthony R Mato, et al.
BMJ Open|October 7, 2021
Impact of social determinants of health on cancer care: a survey of community oncologistsMarjorie E Zettler, Bruce A Feinberg, Yolaine Jeune-Smith, et al.
Future Oncology (London, England)|June 1, 2018
Using Response Evaluation Criteria in Solid Tumors in real-world evidence cancer researchBruce A Feinberg, Murtuza Bharmal, Andrew J Klink, et al.
Advances in Therapy|January 25, 2021
Effectiveness of Eribulin in Metastatic Breast Cancer: 10 Years of Real-World Clinical Experience in the United StatesSarah S Mougalian, Jonathan K Kish, Jingchuan Zhang, et al.
Advances in Therapy|May 16, 2021
Correction to: Effectiveness of Eribulin in Metastatic Breast Cancer: 10 Years of Real-World Clinical Experience in the United StatesSarah S Mougalian, Jonathan K Kish, Jingchuan Zhang, et al.
Advances in Therapy|April 7, 2021
Correction to: Effectiveness of Eribulin in Metastatic Breast Cancer: 10 Years of Real-World Clinical Experience in the United StatesSarah S Mougalian, Jonathan K Kish, Jingchuan Zhang, et al.
Pageof 5